InflaRx N.V. (IFRX)

NASDAQ: IFRX · Real-Time Price · USD

1.260

-0.210 (-14.29%)

At close: Sep 12, 2025, 4:00 PM EDT

1.280

+0.020 (1.59%)

After-hours: Sep 12, 2025, 7:33 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Novel Therapeutic Products	179.33K	Log In
Novel Therapeutic Products Growth	162.93%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	179.33K	Log In
United States Growth	162.93%	Log In